Scarica l'app Stockscreener
39.25
7.30%
2.67
Dopo l'orario di chiusura:
39.34
0.09
+0.23%
Precedente Chiudi:
$36.58
Aprire:
$36.8
Volume 24 ore:
193.37K
Relative Volume:
0.59
Capitalizzazione di mercato:
$1.74B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+15.71%
1M Prestazione:
+38.79%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$35.07
$39.48
Intervallo di 1 settimana:
$32.84
$39.99
Portata 52W:
$24.15
$39.99
Avalyn Pharma Inc Stock (AVLN) Company Profile
Nome
Avalyn Pharma Inc
Settore
Industria
Telefono
(206) 707-0340
Indirizzo
105 W FIRST ST., BOSTON
Compare AVLN vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVLN
Avalyn Pharma Inc
|
39.25 | 1.66B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Avalyn Pharma Inc Borsa (AVLN) Ultime notizie
Avalyn Pharma (NASDAQ:AVLN) Cut to Sell at Wall Street Zen - marketbeat.com
Novo Holdings A/S (AVLN) discloses 8.8% beneficial stake in Avalyn Pharma - Stock Titan
Avalyn Pharma (NASDAQ:AVLN) Hits New 52-Week High Following Better-Than-Expected Earnings - marketbeat.com
AVLN SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Avalyn Pharma Inc. Common Stock (NASDAQ: AVLN) Share Price, AVLN Stock News, AVLN Share Price & Updates - Kalkine
Avalyn Pharma Q2 Results: EPS misses estimate by 22.64% - scanx.trade
Avalyn Pharma (NASDAQ:AVLN) Trading Up 8.2% Following Better-Than-Expected Earnings - marketbeat.com
Form 8K Avalyn Pharma Inc. For: 12 August By Investing.com - Investing.com Nigeria
Avalyn Pharma Inc. Q2 2026: Net loss $(28.9M), EPS $(0.98) — 10-Q Summary - TradingView
Avalyn Pharma's Q2 Net Loss Widens - Yahoo Finance
Avalyn: Q2 Earnings Snapshot - Yahoo Finance
AVLN: Completed Phase 2b trial enrollment and secured $413.5M cash runway into 2029 - TradingView
AVLN: Net loss widened on higher R&D spend; IPO proceeds extend cash runway into 2029 - TradingView
Avalyn Pharma reports Q2 2026 net loss $28.9M; cash $413.5M, runway into 2029 - TradingView
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights - marketscreener.com
Avalyn Pharma Inc. (NASDAQ:AVLN) Given Average Recommendation of "Buy" by Analysts - marketbeat.com
AVLN Stock Price and Chart — NASDAQ:AVLN - TradingView
Avalyn Pharma (AVLN): Norwest Venture Partners discloses 5.1% ownership stake - Stock Titan
Biotech Stocks At 52-Week HighsHALO +20% On Q2 Results, FENC, AVLN, AMLX, CHE - RTTNews
Avalyn Pharma Inc.common stock (AVLN) Stock Price, News, Quote & History - FinancialContent
Avalyn Pharma (NASDAQ:AVLN) Reaches New 52-Week HighTime to Buy? - marketbeat.com
Avalyn Pharma CEO Baranowski: Inhaled Drugs Cut Lung Function Decline to 0.4%, Opening a $42 Billion Market Oral Therapies Can't Reach - finance.biggo.com
Howard Lazarus Net Worth (2026) - GuruFocus
Avalyn Pharma (NASDAQ:AVLN) Shares Gap DownTime to Sell? - MarketBeat
Avalyn Pharma Inc. Revenue Breakdown – NASDAQ:AVLN - TradingView
AVLN|Avalyn Pharma Ord Shs (Proposed)|Price:27.950|Chg%:-1.780 - TradingKey
Adam H. Golden Net Worth (2026) - GuruFocus
Enterprise value to revenue forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Price to sales forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Price to book forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Avalyn Pharma Inc (AVLN:UW): Stock Price, Quote and News - BNN Bloomberg
Avalyn Pharma Inc. (NASDAQ:AVLN) Receives Average Rating of "Buy" from Analysts - MarketBeat
Avalyn Pharma (NASDAQ:AVLN) Shares Up 5.3%Here's Why - MarketBeat
Melissa Rhodes Net Worth (2026) - GuruFocus
The Signal - Nasdaq
AVALYN PHARMA INC (AVLN) News Flow - Moomoo
Avalyn Pharma (AVLN) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
Enterprise value to EBIT forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Enterprise value to EBITDA forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Price to earnings forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 2000 Index - marketscreener.com
Avalyn Pharma Inc Actuals & Estimates (NASDAQ:AVLN) - TradingView
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 2000 Value Benchmark - marketscreener.com
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 2000 Growth Benchmark - marketscreener.com
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 3000E Growth Benchmark - marketscreener.com
AVLN Forecast — Price Target — Prediction for 2027 - TradingView
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell Small Cap Completeness Index - marketscreener.com
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 2500 Index - marketscreener.com
Avalyn Pharma Inc. (AVLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Avalyn Pharma (AVLN) Stock Chart and Price History 2026 - MarketBeat
Avalyn Pharma (AVLN) Stock Trends and Sentiment 2026 - MarketBeat
Avalyn Pharma Inc Azioni (AVLN) Dati Finanziari
Non sono disponibili dati finanziari per Avalyn Pharma Inc (AVLN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):